Elevation Oncology has become the second biotech this week to face calls from an activist investor to wind down the company.

Story March 20 - Elevation Oncology: The biotech is ditching its sole clinical-stage asset in the wake of disappointing phase 1 data and laying off 70% of its staff as a result. The restructuring ...

The layoffs come as the biotech industry struggles. The post Mass. biotech company cuts 90% of workforce appeared first on Boston.com.

Immuno-oncology expert Gera Goverse explains how combination therapies and innovative CAR-T strategies are reshaping the cancer treatment landscape.

There are four emerging powerhouses in China biotech: Henlius, BeiGene, Innovent and ZaiLab. All were founded in the 2010s, ...

Emerging biotech leader AKESF develops Ivonescimab & Cadonilimab; while offering growth potential with US partnerships, ...

Gilead's Trodelvy and Merck's Keytruda improved progression-free survival in PD-L1+ metastatic TNBC in a Phase 3 trial with ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Cardiff Oncology, Inc. (NASDAQ:CRDF) stands against other hot biotech stocks ...

About Alterome Therapeutics, Inc. Alterome Therapeutics, Inc. is a clinical-stage precision oncology biotechnology company developing alteration-specific therapeutics to address high-value and ...

BOSTON, April 08, 2025 (GLOBE NEWSWIRE) -- General Oncology, Inc., a clinical-stage ... Abid brings over 20 years of experience in the biotechnology sector with expertise in financial strategy ...